Return to Home Incidence > Table > Interpret

Interpretation of Incidence Rates Data

Incidence Rate Report for Missouri by County

Non-Hodgkin Lymphoma (All Stages^), 2016-2020

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Rate

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Recent Trends - This is an interpretation of the AAPC/APC:

AAPC/APC (95% Confidence Interval) - the change in rate over time


Other Notes


Line by Line Interpretation of the Report


Missouri6


US (SEER+NPCR)1


Monroe County6


New Madrid County6


Wright County6


Ste. Genevieve County6


Audrain County6


Henry County6


Gasconade County6


Clinton County6


Phelps County6


Morgan County6


Bollinger County6


Ripley County6


Jasper County6


Andrew County6


Pike County6


Douglas County6


McDonald County6


Howard County6


Lincoln County6


Nodaway County6


Livingston County6


Cass County6


Pettis County6


Osage County6


Miller County6


Stoddard County6


Buchanan County6


Iron County6


St. Francois County6


Lawrence County6


Webster County6


Lafayette County6


Johnson County6


Newton County6


Perry County6


Dallas County6


Cooper County6


Ozark County6


Scott County6


St. Clair County6


Clay County6


Butler County6


St. Louis County6


Jefferson County6


St. Charles County6


Franklin County6


Adair County6


Montgomery County6


Saline County6


Bates County6


Stone County6


Cedar County6


Cape Girardeau County6


Greene County6


Christian County6


Wayne County6


Benton County6


Marion County6


Jackson County6


Randolph County6


Macon County6


Boone County6


Platte County6


Vernon County6


Ray County6


Dunklin County6


Barry County6


Callaway County6


Texas County6


Pulaski County6


Laclede County6


Howell County6


Taney County6


Washington County6


St. Louis City6


Cole County6


Crawford County6


Warren County6


Camden County6


Polk County6


Atchison County6 Barton County6 Caldwell County6 Carroll County6 Carter County6 Chariton County6 Clark County6 Dade County6 Daviess County6 DeKalb County6 Dent County6 Gentry County6 Grundy County6 Harrison County6 Hickory County6 Holt County6 Knox County6 Lewis County6 Linn County6 Madison County6 Maries County6 Mercer County6 Mississippi County6 Moniteau County6 Oregon County6 Pemiscot County6 Putnam County6 Ralls County6 Reynolds County6 Schuyler County6 Scotland County6 Shannon County6 Shelby County6 Sullivan County6 Worth County6

Notes:
Created by statecancerprofiles.cancer.gov on 03/29/2024 6:00 am.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Atchison, Barton, Caldwell, Carroll, Carter, Chariton, Clark, Dade, Daviess, DeKalb, Dent, Gentry, Grundy, Harrison, Hickory, Holt, Knox, Lewis, Linn, Madison, Maries, Mercer, Mississippi, Moniteau, Oregon, Pemiscot, Putnam, Ralls, Reynolds, Schuyler, Scotland, Shannon, Shelby, Sullivan, Worth

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

* Data has been suppressed to ensure confidentiality and stability of rate estimates. Counts are suppressed if fewer than 16 records were reported in a specific area-sex-race category. If an average count of 3 is shown, the total number of cases for the time period is 16 or more which exceeds suppression threshold (but is rounded to 3).

Source: SEER and NPCR data. For more specific information please see the table.
Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.

When displaying county information, the CI*Rank for the state is not shown because it's not comparable. To see the state CI*Rank please view the statistics at the US By State level.